PharmaShots Weekly Snapshots (September 27 - October 01, 2021)
Published: Oct 1, 2021 | Tags: BMS, EMA, MAA, Relatlimab, Nivolumab, Metastatic Melanoma
Published: Oct 1, 2021 | Tags: Merck, Ridgeback, Molnupiravir, P-III, MOVe-OUT Trial, COVID-19
Published: Oct 1, 2021 | Tags: Sanofi, Amlitelimab, KY1005, P-IIa, Study, Atopic Dermatitis, EADV 2021
Published: Oct 1, 2021 | Tags: Dermavant, Tapinarof, P-III, PSOARING 3 Study, Plaque Psoriasis, EADV
Published: Oct 1, 2021 | Tags: Novartis, Remibrutinib, LOU064, P-IIb, Study, Chronic Spontaneous Urticaria, EADV
Published: Oct 1, 2021 | Tags: Otsuka, Sumitomo Dainippon, Neuropsychiatric Compounds
Merck to Acquire Acceleron for ~$11.5B
Published: Sept 30, 2021 | Tags: Merck, Acquire, Acceleron, ~$11.5B
Published: Sept 30, 2021 | Tags: Eli Lilly, Tirzepatide, P-III, SURPASS-3 MRI Sub-Study, Type 2 Diabetes
Published: Sept 30, 2021 | Tags: Takeda, JCR, JR-141, Hunter Syndrome
TransMedics' OCS Liver System Receives the US FDA's Approval for Liver Transplantation
Published: Sept 30, 2021 | Tags: TransMedics, OCS Liver System, US, FDA, Approval, Livers Transplantation
Published: Sept 30, 2021 | Tags: Janssen, P-III, EVERGREEN Study, RSV Vaccine, Lower Respiratory Tract Disease, Respiratory Syncytial Virus
Published: Sept 30, 2021 | Tags: Regeneron, REGEN-COV, casirivimab, imdevimab, P-III, Trial, COVID-19, NEJM
Published: Sept 29, 2021 | Tags: Medtronic, Radial Artery Catheter Device, CE Mark, Approval, Neurovascular Diseases
Published: Sept 29, 2021 | Tags: Novartis, ligelizumab, QGE031, P-IIb, Study, Chronic Spontaneous Urticaria
Published: Sept 29, 2021 | Tags: ViiV Healthcare, Dovato, dolutegravir, lamivudine, P-III, TANGO Study, HIV, IDWeek 2021
AstraZeneca to Acquire Caelum for ~500M
Published: Sept 29, 2021 | Tags: AstraZeneca, Acquire, Caelum, ~500M
AbbVie's Qulipta (atogepant) Receives the US FDA's Approval for the Treatment of Migraine
Published: Sept 29, 2021 | Tags: AbbVie, Qulipta, atogepant, US, FDA, Approval, Migraine
Published: Sept 29, 2021 | Tags: Lilly, Erbitux, cetuximab, Braftovi, encorafenib, US, FDA, Approval, Metastatic Colorectal Cancer, BRAF V600E Mutation
Published: Sept 28, 2021 | Tags: Boehringer Ingelheim, Invetx, Veterinary Therapies
ViiV Healthcare Signs an Exclusive License Agreement with Shionogi to Develop S-365598 for HIV
Published: Sept 28, 2021 | Tags: ViiV Healthcare, Shionogi, S-365598, HIV
Eisai Initiates Rolling Submission of BLA to the US FDA for Lecanemab to Treat Alzheimer's Disease
Published: Sept 28, 2021 | Tags: Eisai, BLA, US, FDA, Lecanemab, Alzheimer's Disease
Published: Sept 28, 2021 | Tags: AstraZeneca, Saphnelo, anifrolumab, MHLW, Approval, Systemic Lupus Erythematosus
Published: Sept 28, 2021 | Tags: Innovent, Union, Orismilast, Inflammatory Dermatology Conditions
Published: Sept 28, 2021 | Tags: Bio-Thera, Intract, Soteria, Phloral, Antibody Therapies
Published: Sept 27, 2021 | Tags: Incyte, Syndax, Axatilimab, cGVHD, Fibrotic Diseases
Published: Sept 27, 2021 | Tags: Takeda, Alofisel, darvadstrocel, MHLW, Approval, Complex Perianal Fistulas, Active Luminal CD
Published: Sept 27, 2021 | Tags: Astellas, Seagen, Padcev, enfortumab vedotin, MHLW, Approval, Advanced Urothelial Cancer
Published: Sept 27, 2021 | Tags: JW, Relmacabtagene Autoleucel, P-II, RELIANCE Study, R/R LBCL, CSCO 2021
Published: Sept 27, 2021 | Tags: Innovent, AnHeart, Taletrectinib, AB-106, P-II, TRUST Trial, ROS1-Positive NSCLC, CSCO 2021
Published: Sept 27, 2021 | Tags: Amgen, Repatha, evolocumab, US, FDA, Approval, Heterozygous Familial Hypercholesterolemia
Related Post: https://pharmashots.com/64800/pharmashots-weekly-snapshots-september-20-24-2021/
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com